新闻
ALNY
--
0.00%
--
分析师提供有关医疗保健公司的见解:Alnylam Pharma(ALNY),社区卫生(CYH)和Bausch Health Companies(BHC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY), Community Health (CYH) and Bausch
SmarterAnalyst · 4天前
Brief-Alnylam宣布Oxlumo®(Lumasiran)的Illuminate-A第三阶段研究的临床结果措施取得了积极的早期结果
reuters.com · 5天前
Alnylam Pharmaceuticals在Oxlumo的3期研究中报告了积极的早期结果
MT Newswires · 5天前
分析师提供有关医疗保健公司的见解:Alnylam Pharma(ALNY),Gilead Sciences(GILD)和Humana(HUM)
Analysts fell to the sidelines weighing in on Alnylam Pharma (ALNY), Gilead Sciences (GILD) and Humana (HUM) with neutral ratings, indicating that the
SmarterAnalyst · 04/30 13:45
分析师看好这些医疗保健股:Alnylam Pharma(ALNY),BioMarin Pharmaceutical(BMRN)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma (ALNY), BioMarin Pharmaceutical (BMRN) and
SmarterAnalyst · 04/30 12:15
分析师对以下医疗保健股的看法不一:Alnylam Pharma(ALNY)和Cryolife(CRY)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY) and Cryolife (CRY). Alnylam Pharma
SmarterAnalyst · 04/30 10:45
10-Q:阿尔南制药公司
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Overview We are a global...
Edgar Online - (EDG = 10Q, 10K) · 04/29 20:21
DJ Alnylam Pharmaceuticals,Inc.首席执行官John Maraganore于2021年第一季度业绩-收益电话抄本> ALNY
Dow Jones · 04/29 19:13
Needham维持Alnylam Pharma(ALNY)的买入评级
In a report released today, Joseph Stringer from Needham reiterated a Buy rating on Alnylam Pharma (ALNY), with a price target of $180.00. The company's
SmarterAnalyst · 04/29 18:55
研究警报:CFRA对Alnylam Pharmaceuticals,Inc.的股票持保留意见。
MT Newswires · 04/29 16:04
每日生物技术动向:Adverum的临床挫折,Galera发布数据读取,Moderna投资疫苗生产,Ardelyx决策日
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28)
Benzinga · 04/29 12:15
简报-Alnylam Pharmaceuticals报告2021年第一季度财务业绩
reuters.com · 04/29 12:14
Alnylam Pharmaceuticals报告2021年第一季度财务业绩并强调近期活动
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter...
BusinessWire - BZX · 04/29 12:00
Alnylam Pharmaceuticals,Inc.将举办收入电话会议
ACCESSWIRE · 04/29 10:30
Alnylam Pharmaceuticals Q1调整后的亏损增长
MT Newswires · 04/29 08:37
-Earnings Flash(ALNY)ALNYLAM PHARMACEUTICALS第一季度收入为1.760亿美元,而Street Est为1.685亿美元
MT Newswires · 04/29 08:03
-Earnings Flash(ALNY)ALNYLAM PHARMACEUTICALS报告第一季度亏损-1.64美元,而Street Est则为-1.40美元
MT Newswires · 04/29 08:02
生物技术的未来一周(4月25日至5月1日):FDA对Sol-Gel,Protalix Bio,Ardelyx的决定
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher.
Benzinga · 04/24 13:24
内幕消息趋势:Alnylam Pharmaceuticals内幕消息获得股票奖,按部分进行税收销售,缓解了90天的购买趋势
MT Newswires · 04/21 18:27
内幕消息趋势:Alnylam Pharmaceuticals的内幕消息人士获得股票奖,使用部分税收,中断90天购买趋势
MT Newswires · 04/21 18:27
微牛提供丰富的实时ALNY股票新闻,让你可以通过多个平台了解ALNY股票行情最新动态,这些免费的阿里拉姆制药新闻可以帮助你做出明智投资。
ALNY 简况
Alnylam Pharmaceuticals Inc是一家生物制药公司。该公司从事核糖核酸(RNA)干扰(RNAi)治疗剂的发现、开发和商业化。该公司专注于使用其N-乙酰半乳糖胺(GalNAc)共轭平台来递送小干扰RNA(siRNA)。其研究性RNAi治疗药物的研发重点集中在三个战略治疗领域(STArs):遗传药物,具有多种治疗罕见病的候选药物;心血管疾病,其候选产品针对经过遗传验证的、肝表达的疾病靶标以满足未满足的心血管疾病和代谢疾病的需求;以及肝感染性疾病,其候选产品旨在解决从肝炎开始的肝感染性疾病的全球健康挑战乙型和丁型肝炎病毒感染。